BOSTON SCIENTIFIC CORP — Director's Dealing 2019

Jan 3, 2019

SEC Form 4/A — Form 4/A

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2017-02-28

Reporting Person: Ballinger Kevin J. (EVP & Pres, Interven Cardio)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-28	Performance Share Units	$	A	21502.0000	Acquired	2018-12-31	Common Stock (21502.0000)	Direct

Footnotes

F1: Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which is to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2018.